These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 3524815)

  • 41. Relationship between mutagenicity and DNA adduct formation in mammalian cells for fjord- and bay-region diol-epoxides of polycyclic aromatic hydrocarbons.
    Phillips DH; Hewer A; Seidel A; Steinbrecher T; Schrode R; Oesch F; Glatt H
    Chem Biol Interact; 1991; 80(2):177-86. PubMed ID: 1934148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rates of hydrolysis and extents of DNA binding of 5-methylchrysene dihydrodiol epoxides.
    Melikian AA; Leszczynska JM; Amin S; Hecht SS; Hoffmann D; Pataki J; Harvey RG
    Cancer Res; 1985 May; 45(5):1990-6. PubMed ID: 3986755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid.
    Wood AW; Huang MT; Chang RL; Newmark HL; Lehr RE; Yagi H; Sayer JM; Jerina DM; Conney AH
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5513-7. PubMed ID: 6752950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The mutagenicity of dibenz[a,j]acridine, some metabolites and other derivatives in bacteria and mammalian cells.
    Bonin AM; Rosario CA; Duke CC; Baker RS; Ryan AJ; Holder GM
    Carcinogenesis; 1989 Jun; 10(6):1079-84. PubMed ID: 2655962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds.
    Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenicity of cyclopenta-fused isomers of benz(a)anthracene in bacterial and rodent cells and identification of the major rat liver microsomal metabolites.
    Nesnow S; Leavitt S; Easterling R; Watts R; Toney SH; Claxton L; Sangaiah R; Toney GE; Wiley J; Fraher P
    Cancer Res; 1984 Nov; 44(11):4993-5003. PubMed ID: 6386146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumorigenicity of optical isomers of the diastereomeric bay-region 3,4-diol-1,2-epoxides of benzo(c)phenanthrene in murine tumor models.
    Levin W; Chang RL; Wood AW; Thakker DR; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1986 May; 46(5):2257-61. PubMed ID: 3697970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carcinogenicity and mutagenicity of benz(a)anthracene diols and diol-epoxides.
    Slaga TJ; Huberman E; Selkirk JK; Harvey RG; Bracken WM
    Cancer Res; 1978 Jun; 38(6):1699-704. PubMed ID: 647680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes.
    Yang SK; Bao ZP
    Mol Pharmacol; 1987 Jul; 32(1):73-80. PubMed ID: 3037304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nitrogen-substitution effect on in vivo mutagenicity of chrysene.
    Yamada K; Suzuki T; Kohara A; Kato TA; Hayashi M; Mizutani T; Saeki K
    Mutat Res; 2005 Sep; 586(1):1-17. PubMed ID: 16054434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells.
    Wislocki PG; Wood AW; Chang RL; Levin W; Yagi H; Hernandez O; Dansette PM; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3350-7. PubMed ID: 788898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutagenicity of potassium alkanediazotates and their use as model compounds for activated nitrosamines.
    Hecker LI; Saavedra JE; Farrelly JG; Andrews AW
    Cancer Res; 1983 Sep; 43(9):4078-82. PubMed ID: 6347365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereochemical specificity in the metabolic activation of benzo(c)phenanthrene to metabolites that covalently bind to DNA in rodent embryo cell cultures.
    Pruess-Schwartz D; Baird WM; Yagi H; Jerina DM; Pigott MA; Dipple A
    Cancer Res; 1987 Aug; 47(15):4032-7. PubMed ID: 3607748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further examination of the effects of nitrosylation on Alternaria alternata mycotoxin mutagenicity in vitro.
    Schrader TJ; Cherry W; Soper K; Langlois I
    Mutat Res; 2006 Jul; 606(1-2):61-71. PubMed ID: 16698312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic activation of chrysene in mouse skin: evidence for the involvement of a triol-epoxide.
    Hodgson RM; Weston A; Grover PL
    Carcinogenesis; 1983 Dec; 4(12):1639-43. PubMed ID: 6652874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formation of DNA adducts in mouse skin treated with metabolites of chrysene.
    Phillips DH; Hewer A; Grover PL
    Cancer Lett; 1987 May; 35(2):207-14. PubMed ID: 3581051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of fjord region tetraols and their use in hepatic biotransformation studies of dihydrodiols of benzo[c]chrysene, benzo[g]chrysene and dibenzo[a,l]pyrene.
    Luch A; Platt KL; Seidel A
    Carcinogenesis; 1998 Apr; 19(4):639-48. PubMed ID: 9600349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
    Vyas KP; van Bladeren PJ; Thakker DR; Yagi H; Sayer JM; Levin W; Jerina DM
    Mol Pharmacol; 1983 Jul; 24(1):115-23. PubMed ID: 6865920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further metabolism of diol-epoxides of chrysene and dibenz[a,c]anthracene to DNA binding species as evidenced by 32P-postlabelling analysis.
    Hall M; Parker DK; Hewer AJ; Phillips DH; Grover PL
    Carcinogenesis; 1988 May; 9(5):865-8. PubMed ID: 3365849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.